1Watanabe J, Jobboh T, Hata H, et al. Clinical significance of CA19-9 for endometriosis[J]. Nippon Sanka Fujinka Gakkai Zasshi, 1990,42(2): 155-161.
2Ho HN,Wu MY,Chen SU,et al. Total antioxidant status and nitric oxide do not increase in peritoneal fluids from women with endometriosis[J]. Hum Reprod, 1997,12(12): 2810-2815.
3McBean JH, Brumsted JR. In vitro CA-125 secretion by endometrium from women with advanced endometriosis[J]. Fertil Steril, 1993,59(1):89-92.
4Koninckx PR,Riittinen L,Seppala M,et al. CA-125 and placental protein 14 concentrations in plasma and peritoneal fluid of women with deeply infiltrating pelvic endometriosis[J]. Fertil Steril,1992,57(3): 523-530.
5Toki T, Kubota J, Lu X, et al. Immunohistochemical analysis of CA125,CA19-9 and Ki-67 in stage Ⅲ or Ⅳ endometriosis:Positive correlation between serum CA125 level and endometriotic epithelial cell proliferation[J]. Acta Obstet Gynecol Scand, 2000,79(9):771-776.
6Ishikawa T,NakaoA,Nomoto S,et al. Immunohistochemicl and molecular biological studies of serous cystadenoma of the pancreas[J].Pancreas,1998,16(1):40-44.
2Matlliotakis I,panidis D,Vlassis G,Neonakim,Goumenou A,Koumantakis E.Uneopected increase of the CA199 tomour maker in patients with endometriosis.Eur J Gynecol Oncol,1998,19:498
